Sovaldi (Gilead Sciences, Inc.)
Welcome to the PulseAid listing for the Sovaldi drug offered from Gilead Sciences, Inc.. This Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC],RNA Replicase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Gilead Sciences, Inc. |
| NON-PROPRIETARY NAME: | SOFOSBUVIR |
| SUBSTANCE NAME: | SOFOSBUVIR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC],RNA Replicase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-12-06 |
| END MARKETING DATE: | 0000-00-00 |
Sovaldi HUMAN PRESCRIPTION DRUG Details:
| Item Description | Sovaldi from Gilead Sciences, Inc. |
| LABELER NAME: | Gilead Sciences, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 400(mg/1) |
| START MARKETING DATE: | 2013-12-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61958-1501_5aea47ce-cd27-634b-e053-2991aa0a383a |
| PRODUCT NDC: | 61958-1501 |
| APPLICATION NUMBER: | NDA204671 |
Other SOFOSBUVIR Pharmaceutical Manufacturers / Labelers:
